Warning letter
Pharmacia & Upjohn Co.: warning letter of Dec 2, 1999
FDA warning letter UCM067913 · Detroit District Office
Key facts
| Reference number | UCM067913 |
|---|---|
| Company | Pharmacia & Upjohn Co. |
| Subject | cGMP/Aseptic Drug Manufacturing |
| Issue date | Dec 2, 1999 |
| Posted date | Dec 2, 1999 |
| Issuing office | Detroit District Office |
| Product type | Drugs |
| CFR sections cited | 211.188, 211.192, 2, 211.22, 211.25, 211.42, 211.46, 211.100, 211.84, 211.182 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: